89 related articles for article (PubMed ID: 19592041)
1. Continued validation of the Symptom Inventory in multiple sclerosis.
Motl RW; Schwartz CE; Vollmer T
J Neurol Sci; 2009 Oct; 285(1-2):134-6. PubMed ID: 19592041
[TBL] [Abstract][Full Text] [Related]
2. Physical activity correlates with neurological impairment and disability in multiple sclerosis.
Motl RW; Snook EM; Wynn DR; Vollmer T
J Nerv Ment Dis; 2008 Jun; 196(6):492-5. PubMed ID: 18552627
[TBL] [Abstract][Full Text] [Related]
3. Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
Motl RW; Snook EM
J Neurol Sci; 2008 May; 268(1-2):69-73. PubMed ID: 18061618
[TBL] [Abstract][Full Text] [Related]
4. Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility?
Weikert M; Motl RW; Suh Y; McAuley E; Wynn D
J Neurol Sci; 2010 Mar; 290(1-2):6-11. PubMed ID: 20060544
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal analysis of physical activity and symptoms as predictors of change in functional limitations and disability in multiple sclerosis.
Motl RW; McAuley E
Rehabil Psychol; 2009 May; 54(2):204-10. PubMed ID: 19469611
[TBL] [Abstract][Full Text] [Related]
6. The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis.
Snook EM; Motl RW; Gliottoni RC
Clin Rehabil; 2009 Mar; 23(3):248-58. PubMed ID: 19218299
[TBL] [Abstract][Full Text] [Related]
7. Multiple Sclerosis Walking Scale-12 and oxygen cost of walking.
Motl RW; Dlugonski D; Suh Y; Weikert M; Agiovlasitis S; Fernhall B; Goldman M
Gait Posture; 2010 Apr; 31(4):506-10. PubMed ID: 20226676
[TBL] [Abstract][Full Text] [Related]
8. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.
Baier ML; Cutter GR; Rudick RA; Miller D; Cohen JA; Weinstock-Guttman B; Mass M; Balcer LJ
Neurology; 2005 Mar; 64(6):992-5. PubMed ID: 15781814
[TBL] [Abstract][Full Text] [Related]
9. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.
Hawton A; Green C; Telford CJ; Wright DE; Zajicek JP
Mult Scler; 2012 Jun; 18(6):853-61. PubMed ID: 22108867
[TBL] [Abstract][Full Text] [Related]
10. Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales.
Sonder JM; Bosma LV; van der Linden FA; Knol DL; Polman CH; Uitdehaag BM
Mult Scler; 2012 Feb; 18(2):196-201. PubMed ID: 21908479
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
Goldman MD; Marrie RA; Cohen JA
Mult Scler; 2008 Apr; 14(3):383-90. PubMed ID: 17942508
[TBL] [Abstract][Full Text] [Related]
12. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
Kragt JJ; Thompson AJ; Montalban X; Tintoré M; Río J; Polman CH; Uitdehaag BM
Neurology; 2008 Mar; 70(13 Pt 2):1084-91. PubMed ID: 18184917
[TBL] [Abstract][Full Text] [Related]
13. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
Sormani MP; Rovaris M; Comi G; Filippi M
Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123
[TBL] [Abstract][Full Text] [Related]
14. Validity of performance scales for disability assessment in multiple sclerosis.
Marrie RA; Goldman M
Mult Scler; 2007 Nov; 13(9):1176-82. PubMed ID: 17623733
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of follow-up and disease course].
Roullet E
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1121-3. PubMed ID: 11787343
[TBL] [Abstract][Full Text] [Related]
16. Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
Gray O; McDonnell G; Hawkins S
Mult Scler; 2009 Jan; 15(1):75-80. PubMed ID: 18829636
[TBL] [Abstract][Full Text] [Related]
17. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
Mezei Z; Bereczki D; Csiba L; Csépány T
Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882
[TBL] [Abstract][Full Text] [Related]
18. Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
Bosma L; Kragt JJ; Polman CH; Uitdehaag BM
Mult Scler; 2013 Mar; 19(3):326-33. PubMed ID: 22907939
[TBL] [Abstract][Full Text] [Related]
19. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
[TBL] [Abstract][Full Text] [Related]
20. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
